INDEMNIFICATION AGREEMENTIndemnification Agreement • November 10th, 2015 • Ocata Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Indemnification Agreement (“Agreement”) is made as of by and between Ocata Therapeutics, Inc., a Delaware corporation (the “Company”), and (“Indemnitee”).
AGREEMENT AND PLAN OF MERGER DATED AS OF NOVEMBER 10, 2015 AMONG ASTELLAS PHARMA INC., LAUREL ACQUISITION INC. AND OCATA THERAPEUTICS, INC.Merger Agreement • November 10th, 2015 • Ocata Therapeutics, Inc. • Pharmaceutical preparations • Delaware
AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of November 10, 2015, among ASTELLAS PHARMA INC., a company organized under the laws of Japan (“Parent”), LAUREL ACQUISITION INC., a Delaware corporation and an indirect wholly owned subsidiary of Parent (“Merger Sub”), and OCATA THERAPEUTICS, INC., a Delaware corporation (the “Company”).
SUPPORT AGREEMENTSupport Agreement • November 10th, 2015 • Ocata Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This SUPPORT AGREEMENT (this “Agreement”), dated as of [·], 2015, is entered into by and among [·] (“Stockholder”), ASTELLAS PHARMA INC., a company organized under the laws of Japan (“Parent”), and LAUREL ACQUISITION INC., a Delaware corporation and an indirect wholly owned subsidiary of Parent (“Merger Sub”).
COMMON STOCK PURCHASE WARRANT AMENDMENT AGREEMENT OCATA THERAPEUTICS, INC.Common Stock Purchase Warrant Amendment Agreement • November 10th, 2015 • Ocata Therapeutics, Inc. • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT AMENDMENT AGREEMENT (the “Agreement”) is entered into as of November 9, 2015, by and among Ocata Therapeutics, Inc., a Delaware corporation (the “Company”) and the other parties which are signatories hereto (individually, an “Investor” and collectively, the “Investors”).
